Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease
Authors:
- 20 April 2006
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 259 (5) , 473-480
Abstract
: Increased low‐density lipoprotein (LDL) and decreased high‐density lipoprotein cholesterol (HDL‐C) predict premature coronary artery disease, as do elevated levels of apolipoprotein B or reduced levels of apolipoprotein AI. Probands were studied of families with common genetic forms of dyslipidaemia to determine if apo B or apo AI define genetic groups and if apo B or apo AI levels relate to premature coronary artery disease risk. Elevated apo B was characteristic of familial hypercholesterolaemia, familial combined hyperlipidaemia (FCHL), and was seen in individuals with elevated Lp(a). Normal apo B levels were seen in familial hypertriglyceridaemia and in ‘coronary artery disease with low‐HDL cholesterol’. Apo AI levels tended to be low in FCHL and were decreased in ‘coronary disease with low‐HDL cholesterol’. In familial hypertriglyceraemia, even though HDL‐C levels were low, normal apo AI and apo B levels were seen in the absence of premature coronary artery disease. Therefore, in genetic dyslipidaemias elevated apo B levels and reduced apo AI levels (or increased apo B/AI ratio) differ and predict premature coronary artery disease.Keywords
This publication has 57 references indexed in Scilit:
- Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapyJournal of Internal Medicine, 2006
- Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in MenArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004
- Coronary Artery Disease Risk in Familial Combined Hyperlipidemia and Familial HypertriglyceridemiaCirculation, 2003
- LDL Physical and Chemical Properties in Familial Combined HyperlipidemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Lipid and Lipoprotein Factors Associated With Variation in Lp(a) DensityArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Apolipoprotein A-I-containing particles and reverse cholesterol transport: Evidence for connection between cholesterol efflux and atherosclerosis riskAtherosclerosis, 1994
- Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolaemia and lipoprotein lipase deficiencyThe Lancet, 1993
- Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemiaEuropean Journal of Clinical Investigation, 1980